Serial Assessment of Strut Coverage of Biodegradable Polymer Drug-Eluting Stent at 1, 2, and 3 Months After Stent Implantation by Optical Frequency Domain Imaging
Author(s) -
Bernard Chevalier,
Pieter C. Smits,
Didier Carrié,
Julinda Mehilli,
Ad J. van Boven,
Evelyn Regar,
Fadi J. Sawaya,
Daniel Chamié,
Adriaan O. Kraaijeveld,
Thomas Hovasse,
Georgios J. Vlachojannis
Publication year - 2017
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.116.004801
Subject(s) - medicine , neointimal hyperplasia , stent , drug eluting stent , surgery , clinical endpoint , prospective cohort study , radiology , nuclear medicine , restenosis , randomized controlled trial
To assess the vessel-healing pattern of Ultimaster drug-eluting stent using optical frequency domain imaging. Our hypothesis is that biodegradable polymer-based drug-eluting technology allows complete very early strut coverage.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom